Updating the international standards for tuberculosis care

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 3, 2014, Pages 253-

  Hopewell, Philip C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

COOPERATION; DIRECTLY OBSERVED THERAPY; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL COOPERATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PREDICTIVE VALUE; RISK FACTOR; STANDARDS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; COOPERATIVE BEHAVIOR; DIRECTLY OBSERVED THERAPY; HUMANS; INTERNATIONAL COOPERATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STANDARD OF CARE; TUBERCULOSIS;

EID: 84894248108     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0035     Document Type: Editorial

References (7)

1. Tuberculosis Coalition for Technical Assistance. International standards for tuberculosis care (ISTC). The Hague, The Netherlands: TBCTA, 2006.
2. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational 'how-to': practical considerations. Geneva, Switzerland: WHO, 2011.
3. Steingart K, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013; 1: CD009593
4. Lonnroth K, Raviglione M C. Global epidemiology of tuberculosis: prospects for control. Sem Respir Crit Care Med 2008; 29: 481-491.
5. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
6. World Health Organization. Systematic screening for active t uberculosis: principles and recommendations. Geneva, Switzerland: WHO, 2013.
7. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: a 2011 update. WHO/ HTM/TB/2011.6. Geneva, Switzerland: WHO, 2011.